A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphoma-Reference-Cited by-同舟云学术

A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphoma

Published:2012-05-25 Issue:1 Volume:53 Page:76-84
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Kaufman Jonathan L.,Flowers Christopher R.,Rados Karen D.,Calandra Gary B.,Vose Julie M.,Hewes L. Becker,Lonial Sagar,Langston Amelia A.,Khoury H. Jean,Lechowicz Mary Jo,Waller Edmund K.

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1537-2995.2012.03719.x/fullpdf

Reference21 articles.

1. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma;Philip;N Engl J Med,1995

2. Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma;DiPersio;J Clin Oncol,2009

3. Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma;DiPersio;Blood,2009

4. A phase II study of plerixafor (AMD3100) plus G-CSF for autologous hematopoietic progenitor cell mobilization in patients with Hodgkin lymphoma;Cashen;Biol Blood Marrow Transplant,2008

5. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products;Lonial;Biol Blood Marrow Transplant,2004

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemokines and Lymphoproliferative Disorders;eLS;2015-11-16

2. Evaluation of the spectra Optia® mononuclear cell collection procedure in multiple myeloma patients;Journal of Clinical Apheresis;2014-06-19

3. Current Clinical Indications for Plerixafor;Transfusion Medicine and Hemotherapy;2013